Bioship ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 6.5% 21.1% 11.8%  
Credit score (0-100)  0 0 38 5 20  
Credit rating  N/A N/A BBB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 354 -4.2 0.0  
EBITDA  0.0 0.0 354 -4.2 32.7  
EBIT  0.0 0.0 354 -4.2 32.7  
Pre-tax profit (PTP)  0.0 0.0 352.2 -9.9 32.7  
Net earnings  0.0 0.0 274.1 -9.9 25.5  
Pre-tax profit without non-rec. items  0.0 0.0 352 -9.9 36.5  

 
See the entire income statement

Balance sheet (kDKK) 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 324 314 340  
Interest-bearing liabilities  0.0 0.0 1,088 78.2 18.8  
Balance sheet total (assets)  0.0 0.0 1,501 419 372  

Net Debt  0.0 0.0 -244 -341 -31.1  
 
See the entire balance sheet

Volume 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 354 -4.2 0.0  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 1,501 419 372  
Balance sheet change%  0.0% 0.0% 0.0% -72.1% -11.2%  
Added value  0.0 0.0 353.6 -4.2 32.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 1.0  

Profitability 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 100.0% 100.0% 0.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 23.9% -0.4% 8.3%  
ROI %  0.0% 0.0% 25.4% -0.5% 8.7%  
ROE %  0.0% 0.0% 84.6% -3.1% 7.8%  

Solidity 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  0.0% 0.0% 21.6% 75.0% 91.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -69.1% 8,137.3% -95.1%  
Gearing %  0.0% 0.0% 335.8% 24.9% 5.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 1.1% 1.0% -7.8%  

Liquidity 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.0 0.0 1.3 4.0 11.6  
Current Ratio  0.0 0.0 1.3 4.0 11.6  
Cash and cash equivalent  0.0 0.0 1,332.5 418.7 49.9  

Capital use efficiency 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 324.1 314.2 339.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
N/A
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0